The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aprea Therapeutics, Inc. | COM | 03836J102 | 130,908 | 2,852,654 | SH | SOLE | 2,852,654 | 0 | 0 | ||
| Arvinas, Inc. | COM | 04335A105 | 56,639 | 1,378,423 | SH | SOLE | 1,378,423 | 0 | 0 | ||
| Cabaletta Bio, Inc. | COM | 12674W109 | 51,260 | 3,669,263 | SH | SOLE | 3,669,263 | 0 | 0 | ||
| Cidara Therapeutics, Inc. | COM | 171757107 | 7,705 | 2,006,511 | SH | SOLE | 2,006,511 | 0 | 0 | ||
| Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 59,270 | 2,362,286 | SH | SOLE | 2,362,286 | 0 | 0 | ||
| Homology Medicines, Inc. | COM | 438083107 | 114,594 | 5,535,919 | SH | SOLE | 5,535,919 | 0 | 0 | ||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | 25,973 | 3,463,066 | SH | SOLE | 3,463,066 | 0 | 0 | ||
| scPharmaceuticals Inc. | COM | 810648105 | 18,414 | 3,253,440 | SH | SOLE | 3,253,440 | 0 | 0 | ||
| Viveve Medical, Inc. | COM | 92852W303 | 10 | 8,078 | SH | SOLE | 8,078 | 0 | 0 | ||